Grassley Probes Illegal Marketing of Lilly’s Zyprexa

From the Associated Press' Matthew Perrone, word came today that Senator Charles Grassley had requested emails and other documents from Eli Lilly, after lawsuits suggested that the company had "downplayed risks" and "wrongly promoted" its top-selling drug schizophrenia and bipolar disorder drug, Zyprexa.

Company spokesman Phil Belt said the documents are a small fraction of the 15 million pages affected by the court order. Click here to read the brief update from AP that appeared in Forbes.